- Login
- Register & Subscribe
- Language: EN FR DE
Finance, Grants, Deals
Proximagen makes cash offer for Minster Pharmaceuticals
Wednesday 6 January 2010
Proximagen Neuroscience Plc, a university spin-out that raised £50 million in an initial offer of its shares in 2009, is making an agreed, all-cash offer for Minster Pharmaceuticals Plc. Both companies are developing CNS drug candidates.
Location
United Kingdom
See map: Google Maps
Affitech secures bridge financing
Tuesday 5 January 2010
The Danish antibody developer, Affitech A/S, has negotiated a bridging loan of DKK 9.33 million (€1.25 million) to cover its needs while it negotiates a larger financing during the first quarter. The loan has been extended by three existing investors.
Location
Denmark
Pharming raises €7.5 million in convertible debt
Tuesday 5 January 2010
Pharming Group NV has raised €7.5 million in convertible debt that will help finance its activities while its lead product for hereditary angioedema, Rhucin, is being reviewed by the European Medicines Agency.
Location
Netherlands
See map: Google Maps
Newly-merged Evolva signs discovery deal with Roche
Monday 4 January 2010
The newly merged Swiss company, Evolva Holding SA, has signed a deal with the Roche group to discover compounds with activity on targets in oncology and anti-infectives. The financial terms were not disclosed.
Location
Switzerland
See map: Google Maps
UK bioinformatics spin-out receives funding
Monday 4 January 2010
A bioinformatics company with a focus on biomarker discovery has received seed funding from two UK venture funds in order to carry out its work identifying markers suitable for helping investigators select patients for clinical trials.
Location
United Kingdom
See map: Google Maps
NicOx raises €100 million in two-step capital increase
Wednesday 30 December 2009
NicOx SA of France said it has raised €100 million in a two-step capital increase giving it the financial means to set up a sales force in the US to help commercialise its lead anti-inflammatory drug, naproxcinod, which is being reviewed by the FDA.
Location
France
France’s Novexel to be acquired by AstraZeneca
Monday 28 December 2009
The value to Big Pharma of novel antibiotics has been underscored by AstraZeneca’s decision to acquire Novexel SA of France for a total cash consideration of up to $505 million. Novexel currently has two anti-infectives in Phase 2 development.
Location
France
Innate Pharma raises €24.3 million in share placement
Sunday 20 December 2009
Innate Pharma SA, a pioneer in the field of cancer immunotherapies, has raised €24.3 million gross in a share placement supported by France’s Fonds Stratégique d’Investissement and existing investors, Novo Nordisk A/S and Alta Partners.
Location
France
Silence Therapeutics to merge with Intradigm Corp of the US
Thursday 17 December 2009
Silence Therapeutics Plc, a company that has moved quickly to capitalise on the new science of ribonucleic acid interference (RNAi), has announced plans to merge with the privately-owned Intradigm Corp of the US, which is in the same business.
Location
United Kingdom
See map: Google Maps
Galápagos and GSK expand their discovery alliance in arthritis
Wednesday 16 December 2009
Galápagos NV said that it has expanded its collaboration with GlaxoSmithKline to discover new drugs for multiple indications in the field of arthritis. The two companies are exploring drugs directed at the kinase target GT622.
Location
Belgium
Select a News Category
Recent Appointments
Tim Edwards elected chairman of BIA
Tuesday September 7 2010
Index Ventures appoints antibody expert as partner
Friday September 3 2010
Colin Stewart appointed CEO at Amarin
Friday August 20 2010
Karl Keegan nominated as CFO of Pharming
Friday August 20 2010
Axel Müller becomes CEO at SkyePharma
Thursday August 19 2010